Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -46.46% vs 343.14% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 41.72% vs 92.28% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -6.42% vs 93.97% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -100.00% vs -29.32% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Changjiang Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -46.46% vs 343.14% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 74.10% vs -95.89% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 41.72% vs 92.28% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 67.56% vs -2,261.76% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -6.42% vs 93.97% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 56.52% vs -59.41% in Jun 2024
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






